Order Article Reprints

Brodin O, Eksborg S, Wallenberg M, Asker-Hagelberg C, Larsen EH, Mohlkert D, Lenneby-Helleday C, Jacobsson H, Linder S, Misra S, et al. Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study. Nutrients. 2015; 7(6):4978-4994. https://doi.org/10.3390/nu7064978

Brodin, Ola, Staffan Eksborg, Marita Wallenberg, Charlotte Asker-Hagelberg, Erik H. Larsen, Dag Mohlkert, Clara Lenneby-Helleday, Hans Jacobsson, Stig Linder, Sougat Misra, and et al. 2015. "Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study" Nutrients 7, no. 6: 4978-4994. https://doi.org/10.3390/nu7064978

Brodin, O., Eksborg, S., Wallenberg, M., Asker-Hagelberg, C., Larsen, E. H., Mohlkert, D., Lenneby-Helleday, C., Jacobsson, H., Linder, S., Misra, S., & Björnstedt, M. (2015). Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study. Nutrients, 7(6), 4978-4994. https://doi.org/10.3390/nu7064978